Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for scalp nerve block analgesia after craniotomy
ChiCTR2400087817Phase 4Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine, ropivacaine and sodium chloride in postoperative pain (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: NRS pain score at rest 0-72 hours after surgery. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacainesodium chloride
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400087817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087817.